Federal and Victorian Industry Ministers announce Trajan as manufacturing grant recipient

Federal and Victorian Industry Ministers announce Trajan as manufacturing grant recipient

November 13, 2015

Melbourne, Victoria, Australia - 13 November 2015

Trajan Scientific and Medical (Trajan) has been announced as one of eleven Victorian businesses receiving a total of $27.4 million to establish or expand high value manufacturing operations under the Next Generation Manufacturing Investment Programme.

Minister for Industry, Innovation and Science Christopher Pyne and Victorian Minister for Industry Lily D’Ambrosio made the announcement at Trajan’s Global Headquarters, saying the investment would help to stimulate economic activity and increase business competitiveness in Victoria.

Mr Pyne said the Australian Government is committed to ensuring a strong and sustainable manufacturing industry in Australia by helping businesses innovate and diversify for the future.

“This investment will help to attract private investment in the sector, building our advanced manufacturing capabilities,” said Mr Pyne.

Ms D’Ambrosio agreed the programme will encourage the growth of advanced manufacturing operations, including in the defence, transportation, pharmaceutical and medical device sectors.

“It will leverage capital investment in precision engineering, robotics and advanced composite materials development, and support businesses to access global supply chains,” said Ms D’Ambrosio.

Chief Executive Officer of Trajan, Stephen Tomisich comments: “Trajan’s grant is investing in Advanced Manufacturing of Precision Scientific and Medical Glass Tubing. This project will expand opportunities to new markets, commercialising products for the medical device sector through utilisation of research technologies.”

Mr Tomisich continues: “Trajan believes the Government’s current discussion on transforming funding for research, and aligning with business opportunities, will ensure a future of research and development translating into economic outcomes for this country. We are enthused and excited by the Government’s refreshed recognition of the importance of innovation within the context of collaboration to the nation’s prosperity.”

Mr Pyne and Ms D’Ambrosio’s presence at Trajan comes exactly one week after Australia’s Prime Minister Malcolm Turnbull visited the company, to hear about its pioneering partnerships with academia and start-ups that are set to become a critical new pillar of the Australian economy.

Mr Tomisich commented at the time of Mr Turnbull’s visit: “Rolling out new models to fund and nurture innovative start-ups, taking those brilliant concepts and ideas nestled in the labs and lecture halls of universities – Trajan identifies these opportunities and in doing so, essentially creates new IP-based, successful and sustainable ideas and enterprises that can deliver long-term economic benefit.”


Photo (L-R): Victorian Minister for Industry Lily D’Ambrosio, Minister for Industry, Innovation and Science Christopher Pyne and Member for Deakin Michael Sukkar.

View more photos on Trajan's Facebook or Google+.

More Information
Premier of Victoria - $75M investment for next generation Victorian manufacturing
Michael Sukkar MP - Trajan Scientific and Medical invests in high value manufacturing
Next Generation Manufacturing Investment Programme
 

Download
Trajan Press Release - Australian Media [PDF]

Related News
Trajan welcomes Australian Prime Minister to showcase its ‘disruptive innovation’ with academia and start-ups

Media Contact Information
Trajan Scientific and Medical
media@trajanscimed.com
+61 (0) 3 9837 4200

PR Consultancy: LBPR
lisa@lbpr.com.au
+61 (0) 429 976 718




Also in News

Advantages of hemaPEN blood microsampling validated for therapeutic drug monitoring in RSC’s Analyst
Advantages of hemaPEN blood microsampling validated for therapeutic drug monitoring in RSC’s Analyst

September 07, 2020

Trajan Scientific and Medical’s hemaPEN® has been independently evaluated and the results of the study published in the Royal Society of Chemistry’s journal Analyst - selected for the cover of issue 17. hemaPEN demonstrated significant advantages for blood sampling to support better healthcare decision making.

Read More

European patent for Trajan’s hemaPEN
European patent for Trajan’s hemaPEN

July 13, 2020

Trajan Scientific and Medical is proud to advise that the European Patent Office will be granting a patent for hemaPEN® as a liquid collection device in Belgium, France, Germany, Ireland, Luxembourg, Monaco, Switzerland, Liechtenstein and the United Kingdom. Extensions are being sought across the remainder of Europe.

Read More

US FDA listing of Trajan’s hemaPEN blood microsampling device
US FDA listing of Trajan’s hemaPEN blood microsampling device

July 02, 2020

Trajan Scientific and Medical has listed its hemaPEN® blood microsampling device with the U.S. Food and Drug Administration as Class I for therapeutic and in vitro diagnostic use. This follows the hemaPEN’s recent registration in May for supply in the EU and UK as a General IVD; as well as inclusion in the TGA’s ARTG (Australian Register of Therapeutic Goods) in February as a Class I IVD.

Read More